Skip to main content
MSC-CAR • RESEARCH USE ONLY

Cardiac Progenitor Cells

Cells capable of regenerating cardiomyocytes, smooth muscle, and vascular cells. CPCs can differentiate into cardiomyocytes, endothelial cells, and smooth muscle cells.

Product image for Cardiac Progenitor Cells
Cardiomyocytes · vessels · smooth muscle
CARDIAC LINEAGE BREADTH
— Progenitors that regenerate myocardium, smooth muscle, and vascular cells — a multi-compartment cardiac repair toolkit.
Angiogenesis · less fibrosis
POST-INJURY PARACRINE PROGRAM
— Research highlights new vessel formation, apoptosis/fibrosis modulation, and improved cardiac function after ischemic or structural injury.
Allogeneic-friendly
TRANSLATIONAL PROFILE
— Comparatively favorable allogeneic profile while supporting myocardial repair pathways after infarction or chronic dysfunction.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenousIMIntramuscular
Quantities
10 Million Cells2ml
25 Million Cells5ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Congestive Heart Failure (CHF)
  • Post-Myocardial Infarction (MI) Repair
  • Ischemic Cardiomyopathy
  • Coronary Artery Disease
  • Arrhythmias
  • Hypertrophic and Dilated Cardiomyopathies
  • Angina
  • Cardiac Fibrosis
  • Congenital Heart Disorders
  • Congenital Heart Defects
  • Cardiomyopathies

Compliance · Stem cells

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup